Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

The use of U-500 regular insulin in the management of patients with obesity and insulin resistance.

Jones P, Idris I.

Diabetes Obes Metab. 2013 Oct;15(10):882-7. doi: 10.1111/dom.12094. Epub 2013 Apr 4. Review.

PMID:
23489348
2.

Practice tips and tools for the successful use of U-500 regular human insulin: the diabetes educator is key.

Cochran EK, Valentine V, Samaan KH, Corey IB, Jackson JA.

Diabetes Educ. 2014 Mar-Apr;40(2):153-65. doi: 10.1177/0145721713508822. Epub 2013 Oct 24. Review.

PMID:
24159006
3.

Safety and effectiveness of U-500 insulin therapy in patients with insulin-resistant type 2 diabetes mellitus.

Quinn SL, Lansang MC, Mina D.

Pharmacotherapy. 2011 Jul;31(7):695-702. doi: 10.1592/phco.31.7.695.

PMID:
21923457
4.

The effect of long-term use of U-500 insulin via continuous subcutaneous infusion on durability of glycemic control and weight in obese, insulin-resistant patients with type 2 diabetes.

Lane WS, Weinrib SL, Rappaport JM, Hale CB, Farmer LK, Lane RS.

Endocr Pract. 2013 Mar-Apr;19(2):196-201. doi: 10.4158/EP12226.OR.

PMID:
23186973
5.

Continuous subcutaneous insulin infusion versus multiple daily injections in adolescents with type I diabetes mellitus: a randomized open crossover trial.

Cohen D, Weintrob N, Benzaquen H, Galatzer A, Fayman G, Phillip M.

J Pediatr Endocrinol Metab. 2003 Sep;16(7):1047-50. No abstract available.

PMID:
14513883
6.

High-dose insulin therapy: is it time for U-500 insulin?

Lane WS, Cochran EK, Jackson JA, Scism-Bacon JL, Corey IB, Hirsch IB, Skyler JS.

Endocr Pract. 2009 Jan-Feb;15(1):71-9. Review.

7.

External insulin pump treatment in the day-to-day management of diabetes: benefits and future prospectives.

Hanaire H.

Diabetes Metab. 2011 Dec;37 Suppl 4:S40-7. doi: 10.1016/S1262-3636(11)70964-8. Review.

PMID:
22208709
8.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
9.

Importance of daily plasma glucose control in type 2 diabetes.

Pollom RD.

J Fam Pract. 2009 Aug;58(8 Suppl):S10-7. No abstract available.

PMID:
19679026
10.

Effect of insulin glargine on glycaemic control and weight in obese and non-obese people with type 2 diabetes: data from the AT.LANTUS trial.

Khunti K, Srinivasan BT, Shutler S, Davies MJ.

Diabetes Obes Metab. 2010 Aug;12(8):683-8. doi: 10.1111/j.1463-1326.2010.01217.x.

PMID:
20590745
11.
12.

A novel use of U-500 insulin for continuous subcutaneous insulin infusion in patients with insulin resistance: a case series.

Knee TS, Seidensticker DF, Walton JL, Solberg LM, Lasseter DH.

Endocr Pract. 2003 May-Jun;9(3):181-6.

PMID:
12917058
13.

Clinical effects of once-weekly exenatide for the treatment of type 2 diabetes mellitus.

Ryan GJ, Moniri NH, Smiley DD.

Am J Health Syst Pharm. 2013 Jul 1;70(13):1123-31. doi: 10.2146/ajhp120168. Review.

PMID:
23784159
14.

Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.

Darmon P, Curtillet C, Boullu S, Laugier A, Dutour A, Oliver C.

Diabetes Care. 1998 Sep;21(9):1575. No abstract available.

PMID:
9727917
16.
17.

Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes: A retrospective claims analysis.

Lynch P, Riedel AA, Samant N, Fan Y, Peoples T, Levinson J, Lee SW.

Prim Care Diabetes. 2010 Dec;4(4):209-14. doi: 10.1016/j.pcd.2010.07.004. Epub 2010 Sep 15.

PMID:
20832374
18.

Self-titration of insulin in the management of people with type 2 diabetes: a practical solution to improve management in primary care.

Khunti K, Davies MJ, Kalra S.

Diabetes Obes Metab. 2013 Aug;15(8):690-700. doi: 10.1111/dom.12053. Epub 2013 Jan 29. Review.

PMID:
23253563
19.

Early insulin treatment in type 2 diabetes: what are the pros?

Meneghini LF.

Diabetes Care. 2009 Nov;32 Suppl 2:S266-9. doi: 10.2337/dc09-S320. Review. No abstract available.

20.

Use of continuous subcutaneous insulin infusion pump in patients with type 2 diabetes mellitus.

Nielsen S, Kain D, Szudzik E, Dhindsa S, Garg R, Dandona P.

Diabetes Educ. 2005 Nov-Dec;31(6):843-8.

PMID:
16288091

Supplemental Content

Support Center